Literature DB >> 17729413

Dyslipidemia and H pylori in gastric xanthomatosis.

Sun Young Yi1.   

Abstract

AIM: To investigate the relationship among gastric xanthomatosis (GX), H pylori, dyslipidemia, and gastritis in Korea, a well-known H pylori endemic area.
METHODS: A total of 771 patients who had undergone gastroduodenoscopy by one endoscopist were included in this study. Among them, 54 patients with GX were assessed for H pylori infection and their endoscopic characteristics and serum lipid profiles. The findings were compared with 54 age- and sex-matched control subjects without GX.
RESULTS: The prevalence of GX was 7% (54/771) with no sex difference. GX was mainly single (64.8%) and located in the antrum (53.7%). The mean diameter was 7 +/- 3 mm. Mean body mass index (BMI) of patients with GX was 23.1 +/- 2.8 and no one was above 30. Compared with the controls, lipid profiles of GX group showed significantly lower HDL-cholesterol (48.8 +/- 12.3 vs 62.9 +/- 40.5, P = 0.028) and higher LDL-cholesterol (112.9 +/- 29.9 vs 95.9 +/- 22.4, P = 0.032). The level of total serum cholesterol, triglyceride and the existence of dyslipoproteinemia were not related to the presence of GX. However, GX showed a close relationship with endoscopically determined atrophic gastritis and histologic severity (24/53, 44.4% vs 8/54, 14.8%, P = 0.0082). H pylori infection and bile reflux gastritis were not significantly related with GX.
CONCLUSION: The prevalence of GX is 7% and it may be an increasing entity in Korea. Moreover, dyslipidemia and atrophic gastritis are found to be related to GX, but H pylori infection is not.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729413      PMCID: PMC4611834          DOI: 10.3748/wjg.v13.i34.4598

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  Gastric xanthomas.

Authors:  J Oviedo; N Swan; F A Farraye
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

2.  Helicobacter pylori infection in gastric xanthomas: immunohistochemical analysis of 145 lesions.

Authors:  S Hori; Y Tsutsumi
Journal:  Pathol Int       Date:  1996-08       Impact factor: 2.534

3.  A close relationship between Helicobacter pylori infection and gastric xanthoma.

Authors:  H Isomoto; Y Mizuta; K Inoue; T Matsuo; T Hayakawa; M Miyazaki; K Onita; F Takeshima; K Murase; I Shimokawa; S Kohno
Journal:  Scand J Gastroenterol       Date:  1999-04       Impact factor: 2.423

Review 4.  The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment.

Authors:  M Stolte; A Meining
Journal:  Can J Gastroenterol       Date:  2001-09       Impact factor: 3.522

5.  Xanthoma of the stomach--some morphometrical peculiarities and scanning electron microscopy.

Authors:  S Petrov; J Churtchev; R Mitova; L Boyanova; M Tarassov
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

Review 6.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

Authors:  M F Dixon; R M Genta; J H Yardley; P Correa
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

7.  Lipid islands in the gastric mucosa after resection for benign ulcer disease.

Authors:  L Domellöf; S Eriksson; H F Helander; K G Janunger
Journal:  Gastroenterology       Date:  1977-01       Impact factor: 22.682

8.  Type IIa early gastric cancer with proliferation of xanthoma cells.

Authors:  A Muraoka; I Suehiro; M Fujii; H Ueno; S Hayashi; K Shimizu; R Kitazawa; S Kitazawa; K Murakami
Journal:  J Gastroenterol       Date:  1998-06       Impact factor: 7.527

9.  Gastric xanthoma.

Authors:  A Mast; A Eelwaut; G Mortier; J Quatacker; E Defloor; H Roels; F Barbier
Journal:  Am J Gastroenterol       Date:  1976-04       Impact factor: 10.864

10.  Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum.

Authors:  A Watanabe; A Yoshimura; T Wakasugi; R Tatami; K Ueda; R Ueda; T Haba; T Kametani; J Koizumi; S Ito; M Ohta; S Miyamoto; H Mabuchi; R Takeda
Journal:  Atherosclerosis       Date:  1981 Feb-Mar       Impact factor: 5.162

View more
  7 in total

1.  Xanthomas of the stomach: a report of two cases.

Authors:  Bojana M Andrejić; Snežana V Božanić; Nenad S Solajić; Matilda A Djolai; Aleksandra M Levakov
Journal:  Bosn J Basic Med Sci       Date:  2012-05       Impact factor: 3.363

Review 2.  Management of gastric polyps: a pathology-based guide for gastroenterologists.

Authors:  Susanne W Carmack; Robert M Genta; David Y Graham; Gregory Y Lauwers
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06       Impact factor: 46.802

3.  Is Gastric Xanthelasma an Alarming Endoscopic Marker for Advanced Atrophic Gastritis and Intestinal Metaplasia?

Authors:  Aydın Şeref Köksal; Nuretdin Suna; İsmail Hakkı Kalkan; Ahmet Tarık Eminler; Şükran Ziyşan Sakaoğulları; Nesrin Turhan; Fatih Saygılı; Ufuk Barış Kuzu; Erkin Öztaş; Erkan Parlak
Journal:  Dig Dis Sci       Date:  2016-06-01       Impact factor: 3.199

4.  Gastric xanthelasma and metabolic disorders: A large retrospective study among Chinese population.

Authors:  Yi Chen; Xin-Jue He; Min-Jian Zhou; You-Ming Li
Journal:  World J Gastroenterol       Date:  2017-11-21       Impact factor: 5.742

5.  Nodular Esophageal Xanthoma: A Case Report and Review of the Literature.

Authors:  Ahmed Dirweesh; Muhammad Khan; Sumera Bukhari; Cheryl Rimmer; Robert Shmuts
Journal:  Case Rep Gastrointest Med       Date:  2017-04-10

6.  Gastric Xanthoma Is Related to the Rapid Growth of Gastric Cancer.

Authors:  Ko Miura; Tadayuki Oshima; Akio Tamura; Ken Hara; Takuya Okugawa; Masashi Fukushima; Toshihiko Tomita; Hirokazu Fukui; Hiroto Miwa
Journal:  J Clin Med       Date:  2021-12-05       Impact factor: 4.241

Review 7.  Gastric Xanthoma Associated with Gastric Cancer Development: An Updated Review.

Authors:  Faycal Awaleh Moumin; Abdimajid Ahmed Mohamed; Abdirahman Ahmed Osman; Jianting Cai
Journal:  Can J Gastroenterol Hepatol       Date:  2020-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.